Contrastive learning of adverse events to provide effective and interpretable vector representations for machine-assisted pharmacovigilance
Balogh, O. M.; Petervari, M.; Csernak, A. M.; Puhl, E.; Horvath, A.; Ferdinandy, P.; Agg, B.
Show abstract
Post-marketing surveillance is crucial for drug safety, yet the tools of pharmacovigilance rely solely on text-based data that may limit the applicability of contemporary machine learning methodologies in the support of decision making. Here, we adapt contrastive learning algorithms to generate adverse event vector representations from spontaneous reports to serve as general machine-readable resources for pharmacovigilance applications. We present comprehensive analyses of the resulting representations through density-based clustering, semantic evaluation and comparison of multivariate dispersions, revealing patterns that reflect both functional and causal relations of the adverse events while also capturing drug-safety related information better than existing medical terminologies and encoder-only large language models (LLMs). Furthermore, we demonstrate the applicability of the representations as input features in our downstream model, outperforming the reporting odds ratio method commonly used by regulatory agencies (AUROC: 0.88 vs 0.75) and LLM-based representations (AUROC: 0.88 vs 0.83) on drug-event causality prediction benchmarks. As such, this is the first demonstration of an interpretable adverse event vector representation that can be utilized for training arbitrary models, enabling wider and more effective applications of machine learning in pharmacovigilance.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Interpretable Deep Learning for Improving Cancer Patient Survival Based on Personal Transcriptomes 95%
- Generalizing predictions to unseen sequencing profiles via deep generative models 95%
- COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19 94%
Similar papers in this journal
- Adding stochastic negative examples into machine learning improves molecular bioactivity prediction 96%
- BOLD-GPCRs: A Transformer-Powered App for Predicting Ligand Bioactivity and Mutational Effects Across Class A GPCRs 95%
- Improving the reliability of molecular string representations for generative chemistry 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.